1. Home
  2. ESPR vs PRCH Comparison

ESPR vs PRCH Comparison

Compare ESPR & PRCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.66

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

PRCH

Porch Group Inc.

HOLD

Current Price

$7.51

Market Cap

753.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
PRCH
Founded
2008
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
731.9M
753.7M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
ESPR
PRCH
Price
$2.66
$7.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
8
Target Price
$7.60
$18.00
AVG Volume (30 Days)
5.2M
976.7K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
60.71
90.91
EPS
N/A
N/A
Revenue
$403,135,000.00
$482,414,000.00
Revenue This Year
$2.92
$3.86
Revenue Next Year
N/A
$16.83
P/E Ratio
N/A
N/A
Revenue Growth
21.31
10.18
52 Week Low
$0.73
$4.65
52 Week High
$4.18
$19.44

Technical Indicators

Market Signals
Indicator
ESPR
PRCH
Relative Strength Index (RSI) 41.86 49.38
Support Level $2.37 $6.36
Resistance Level $3.02 $8.29
Average True Range (ATR) 0.18 0.43
MACD 0.03 0.02
Stochastic Oscillator 37.62 54.98

Price Performance

Historical Comparison
ESPR
PRCH

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.

Share on Social Networks: